Anti-FcεR1a mAb immunostaining demonstrated the anticipated accumulation of donor FcεR1a-positive BMMCs from Apoe−/− mice in Apoe−/−Fcer1a−/− recipient mouse AAA lesions (Supplementary Fig S8C and Fig 4A, left two panels). This evidence concerns the gene APOE and triple-A syndrome.